Lactic acidosis: a unique presentation of diffuse large B-cell lymphoma.
Turab Jawaid MohammedRohit GosainRajeev SharmaPallawi TorkaPublished in: BMJ case reports (2019)
An elderly man in the seventh decade of life was brought to the hospital with worsening mental status. Blood tests revealed anaemia and thrombocytopenia with elevated lactate dehydrogenase and serum lactate levels. CT scan showed bulky thoracic and abdominal lymphadenopathy with splenomegaly. A positron emission tomography scan confirmed the above and in addition, revealed bilateral adrenal involvement. Bone marrow biopsy revealed non-germinal centre B-cell-like (non-GCB)-diffuse large B-cell lymphoma (DLBCL). Prompt treatment with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab with intrathecal methotrexate chemotherapy resulted in a dramatic improvement in the patient's condition. This vignette serves as a reminder to include aggressive lymphomas like DLBCL in the differential diagnoses of patients presenting with metabolic encephalopathy and lactic acidosis. Our patient was moribund at presentation with poor sensorium and failure to thrive. The dilemma was whether to take an aggressive stand and start chemotherapy urgently or whether to stabilise the patient first and then consider the treatment of DLBCL. We make a case for initiating therapy promptly in such patients irrespective of their performance status.
Keyphrases
- diffuse large b cell lymphoma
- computed tomography
- case report
- positron emission tomography
- epstein barr virus
- bone marrow
- end stage renal disease
- single cell
- high dose
- chronic kidney disease
- healthcare
- ejection fraction
- locally advanced
- newly diagnosed
- low dose
- magnetic resonance imaging
- prognostic factors
- spinal cord
- ultrasound guided
- middle aged
- drug delivery
- emergency department
- image quality
- fine needle aspiration
- replacement therapy
- patient reported
- early onset
- cancer therapy